Intarcia Therapeutics is an American biopharmaceutical company based in Boston, MA and incorporated under the laws of Delaware. It was founded in 1995 under the name "BioMedicines" and changed to its present name in 2004. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Intarcia Therapeutics (United States), United States, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
61%
Total
Publications
96
Total Open
Publications
59
Total
Citations
4.3K
Open Access
Percentage
61%
Total
Publications
96
Total Open
Publications
59
Total
Citations
4.3K
Breakdown
Publisher Open
26%
Both
23%
Other Platform Open
7%
Closed
44%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 32%
13
Hybrid 32%
13
No Guarantees 36%
15
Other Platform Open
Domain 90%
28
Institution 19%
6
Other Internet 3%
1
Preprint 0%
0
Public 0%
0
Other Platform Locations
Name | Platform Type | Publications |
---|---|---|
PubMed Central | Domain | 28 |
DANS - Data Archiving and Networked Services | Institution | 3 |
U.S. Department of Energy Office of Scientific and Technical Information - OSTI OAI | Institution | 2 |
Europe PMC | Domain | 2 |
PUBDB - DESY Publication Database | Institution | 1 |
Massachusetts Institute of Technology - DSpace@MIT | Institution | 1 |
Imperial College London - Spiral | Institution | 1 |
DOI | Other Internet | 1 |